Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2018 | 2 |
2021 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
Int J Mol Sci. 2021 Jun 15;22(12):6413. doi: 10.3390/ijms22126413.
Int J Mol Sci. 2021.
PMID: 34203923
Free PMC article.
Review.
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
Cormerais Y, Massard PA, Vucetic M, Giuliano S, Tambutté E, Durivault J, Vial V, Endou H, Wempe MF, Parks SK, Pouyssegur J.
Cormerais Y, et al. Among authors: durivault j.
J Biol Chem. 2018 Feb 23;293(8):2877-2887. doi: 10.1074/jbc.RA117.001342. Epub 2018 Jan 11.
J Biol Chem. 2018.
PMID: 29326164
Free PMC article.
Item in Clipboard
Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma.
Dumond A, Brachet E, Durivault J, Vial V, Puszko AK, Lepelletier Y, Montemagno C, Pagnuzzi-Boncompagni M, Hermine O, Garbay C, Lagarde N, Montes M, Demange L, Grépin R, Pagès G.
Dumond A, et al. Among authors: durivault j.
J Exp Clin Cancer Res. 2021 Jan 18;40(1):33. doi: 10.1186/s13046-021-01832-x.
J Exp Clin Cancer Res. 2021.
PMID: 33461580
Free PMC article.
Item in Clipboard
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.
Montemagno C, Jacquel A, Pandiani C, Rastoin O, Dawaliby R, Schmitt T, Bourgoin M, Palenzuela H, Rossi AL, Ambrosetti D, Durivault J, Luciano F, Borchiellini D, Le Du J, Gonçalves LCP, Auberger P, Benhida R, Kinget L, Beuselinck B, Ronco C, Pagès G, Dufies M.
Montemagno C, et al. Among authors: durivault j.
J Exp Clin Cancer Res. 2024 Mar 19;43(1):86. doi: 10.1186/s13046-024-02984-2.
J Exp Clin Cancer Res. 2024.
PMID: 38504270
Free PMC article.
Item in Clipboard
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M, Brand A, Di Ianni L, Dettmer K, Reinders J, Singer K, Peter K, Schnell A, Bruss C, Decking SM, Koehl G, Felipe-Abrio B, Durivault J, Bayer P, Evangelista M, O'Brien T, Oefner PJ, Renner K, Pouysségur J, Kreutz M.
Ždralević M, et al. Among authors: durivault j.
J Biol Chem. 2018 Oct 12;293(41):15947-15961. doi: 10.1074/jbc.RA118.004180. Epub 2018 Aug 29.
J Biol Chem. 2018.
PMID: 30158244
Free PMC article.
Item in Clipboard
Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: a new paradigm for understanding the therapeutic effect of combined treatment.
Ortholan C, Durivault J, Hannoun-Levi JM, Guyot M, Bourcier C, Ambrosetti D, Safe S, Pagès G.
Ortholan C, et al. Among authors: durivault j.
Eur J Cancer. 2010 Nov;46(16):3022-36. doi: 10.1016/j.ejca.2010.07.021. Epub 2010 Aug 20.
Eur J Cancer. 2010.
PMID: 20729074
Item in Clipboard
Cite
Cite